Dianne Knapp
Family · Keosauqua, IANPI 1760482426
Payments from drug & device makers
Across 57 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$106
- AbbVie$93
- AstraZeneca$74
- Amgen$60
- Amarin Pharma, Inc.$60
- Pfizer$55
- plus $479 from 19 others
What the payments were for
- Food & beverage$927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 6 | $106 |
| AbbVie | 6 | $93 |
| AstraZeneca | 4 | $74 |
| Amgen | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $60 |
| Pfizer | 4 | $55 |
| Novo Nordisk | 3 | $45 |
| Johnson & Johnson | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Medtronic | 1 | $29 |
| Lilly USA, LLC | 2 | $27 |
| GSK | 2 | $26 |
| Mylan Specialty L.p. | 2 | $25 |
| Merck | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Exact Sciences | 1 | $16 |
| Bayer | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$927 in reported general payments places this provider in the 75th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 63 | $63,225 |
| FarxigaDapagliflozin Propanediol | 34 | $24,525 |
| EliquisApixaban | 32 | $21,903 |
| XareltoRivaroxaban | 13 | $13,856 |
| Omeprazole | 64 | $765 |
| Cefdinir | 31 | $649 |
| Diclofenac Sodium | 12 | $634 |
| Tamsulosin Hcl | 42 | $430 |
| Atorvastatin Calcium | 69 | $339 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $331 |
| Gabapentin | 32 | $323 |
| Lisinopril | 73 | $314 |
| Cephalexin | 27 | $297 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $278 |
| Losartan Potassium | 54 | $266 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $45 | $63,22563 claims |
| AstraZenecaFarxiga | $74 | $24,52534 claims |
| PfizerEliquis | $55 | $21,90332 claims |
| Johnson & JohnsonXarelto | $42 | $13,85613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,268 family providers in Iowa.
Other family in Keosauqua
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.